Skip to content

PrEP rollout recipients in France top 1000: full trial results report 97% effectiveness

Jean-Michel Molina presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most

Craig Wilson presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Australia adopts ambitious plan to use PrEP to ‘virtually eliminate’ HIV by 2020

Image from presentation by Iryna Zablotska, The Kirby Institute

PrEP can further reduce the risk of HIV infection after a partner starts treatment

Jared Baeten presenting at AIDS 2016. Photo by Jan Brittenson, hivandhepatitis.com

Young gay men can do well on PrEP, but may need more support

Sybil Hosek presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.com

Comprehensive services for sex workers reduce detectable viral load, but enhanced ARV services provide no extra benefit

Frances Cowan presenting at AIDS 2016. Photo by Roger Pebody, aidsmap.com

PrEP use exceeds 79,000 in US pharmacy survey, but some groups lagging behind

Scott McCallister presenting at AIDS 2016. Photo by Jan Brittenson, hivandhepatitis.com

PrEP researchers now focusing on the best ways to get PrEP to people who need it

Linda-Gail Bekker presenting at AIDS 2016. Photo©International AIDS Society/Steve Forrest/Workers' Photos

HIV seroconversion is rare if Truvada PrEP is used consistently

Slide from Gilead presentation at ASM Microbe 2016.